Michigan Medicine
Hematologic Malignancies Symposium
2023-
Michigan Medicine
Hematologic Malignancies Symposium
2023-
THE KENSINGTON HOTEL, ANN ARBOR
7:00-7:30 Registration and continental Breakfast
7:30-7:35 Welcome
Ryan Wilcox, MD, PhD
Michigan Medicine, Division of Hematology Oncology; Section Head, Lymphoma and Myeloma
7:35-8:30 Boston Drivers and Other Goofy Car Analogies to Understanding Myeloid Mutational Patterns
Annette Kim, MD, PhD
Michigan Medicine, Molecular and Genomic Pathology
8:30-9:00 CAR’s and Auto’s: When should I refer my patient for an allo?
John Magenau, MD
Michigan Medicine, Division of Hematology Oncology, Adult Blood and Marrow Transplantation
9:00-10:00 Concurrent Round Tables: Myeloma and MPN
Myeloma: Matt Pianko, MD, and Erica Campagnaro, MD, Michigan Medicine; P. Leif Bergsagel, MD, Mayo Clinic
MPN: Kristin Pettit, MD, Moshe Talpaz, MD, Lydia Benitez, PharmD, and Annette Kim, MD PhD, Michigan Medicine
10:00-10:30 Coffee Break and Networking
10:30-11:30 Concurrent Round Tables: Lymphoma and MDS/AML
Lymphoma: Mark Kaminski, MD, Ryan Wilcox, MD, PhD, Yasmin Karimi, MD, and Shannon Carty, MD, Michigan Medicine
MDS/AML: Kristen Pettit, MD, Dale Bixby, MD, PhD, Bernard Marini, PharmD, and Anthony Perissinotti, PharmD, Michigan Medicine
11:30-12:15 Buffet Lunch
12:15-1:15 Keynote Address
P. Leif Bergsagel, MD
Mayo Clinic, Division of Hematology, Phoenix, Arizona
1:15-1:45 CLL Update
Sami Malek, MD
Michigan Medicine, Division of Hematology Oncology
1:45-2:15 Current Controversies in the Prevention and Management of Cancer Associated Thrombosis
Jordan Schaefer, MD
Michigan Medicine, Division of Hematology Oncology
2:15-2:40 Immunology 101
Shannon Carty, MD
Michigan Medicine, Division of Hematology Oncology
2:40-3:00 Coffee Break and Networking
3:00-3:30 Managing Bispecific Antibody Toxicity
Yasmin Karimi, MD
Michigan Medicine, Division of Hematology Oncology
3:30-4:00 First line treatment of MCL
Tycel Phillips, MD
City of Home Comprehensive Cancer Center, Los Angeles, CA
4:00-4:30 Debate: Hot Topics in MDS/AML
Dale Bixby, MD, PhD, Michigan Medicine, Division of Hematology Oncology
Bernard Marini, PharmD, Michigan Medicine, Pharmacy
Anthony Perissinotti, PharmD, Michigan Medicine, Pharmacy
4:30 Closing
7:00-8:00 Registration and Continental Breakfast
8:00-8:05 Welcome
Ryan Wilcox, MD, PhD
Michigan Medicine, Division of Hematology Oncology; Section Head, Lymphoma and Myeloma
8:05-8:30 My Patient has a T-Cell Lymphoma, Now What?
Ryan Wilcox, MD, PhD
8:30-9:00 DLBCL Management: A State-of-the-Art Review
Yasmin Karimi, MD
Michigan Medicine, Division of Hematology Oncology
9:00-9:30 The Road There and Back Again. The Journey of Immunotherapy in Lymphoma
Tycel Phillips, MD
City of Hope Comprehensive Cancer Center, Los Angeles, CA
9:30-10:00 Frontline Management of Myeloma: A State-of-the-Art Review
Matt Pianko, MD
Michigan Medicine, Division of Hematology Oncology
10:00-10:30 Coffee Break and Networking
10:40-11:10 Advances in the Management of Relapsed/ refractory Myeloma
Erica Campagnaro, MD
Michigan Medicine, Division of Hematology Oncology
11:10-11:40 Advances in CAR T-cell Therapy for Lymphoma
Monalisa Ghosh, MD
Michigan Medicine, Division of Hematology Oncology
12:00-1:00 Buffet Lunch
1:00-2:00 Keynote Address: Myeloproliferative Neoplasms: 2023 update
Ayalew Tefferi, MD
Barbara Woodward Lips Professor of Medicine, Mayo Clinic, Division of Hematology, Rochester, MN
2:00-2:20 Clinical Debates in AML
Dale Bixby, MD, PhD, Michigan Medicine, Division of Hematology Oncology
Bernard Marini, PharmD, Michigan Medicine, Pharmacy
Anthony Perissinotti, PharmD, Michigan Medicine, Pharmacy
2:40-3:05 CML: Past and Present
Moshe Talpaz, MD
Michigan Medicine, Division of Hematology Oncology
Alexander J. Trotman Professor for Leukemia Research, Associate Division Chief for Hematology
3:05-3:30 Challenging MPN Cases
Kristen Pettit, MD
Michigan Medicine, Division of Hematology Oncology
3:30-3:40 Closing Remarks
Moshe Talpaz, MD
3:40-4:30 Hors d’oeuvres and Networking Reception